Clinical Trial Update: Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT) [Phase 3]

View source ↗

Summary

ASSET-IT is a Phase 3 trial evaluating early tirofiban administration after intravenous thrombolysis for acute ischemic stroke; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• tirofiban (tirofiban)

Snippet

Sponsor: The First Affiliated Hospital of University of Science and Technology of China | Conditions: Acute Ischemic Stroke | Phase 3 | Status: COMPLETED